HEALTH
August 28, 2006 | By Linda Marsa, Special to The Times
Among the most promising gene therapy trials are ones to treat various forms of cancer. More than 100 of these are in the works, taking a variety of approaches: using genes to ramp up the immune system or block the action of other, cancer-causing genes, to name a couple. Most of these -- and, indeed, all gene therapy treatments -- are still in the early stages of development. But one therapy could be on the market in the U.S. within the year.